The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ceftriaxone 1 g powder for solution for injection/infusion

AS KalceksPA2165/017/001

Main Information

Trade NameCeftriaxone 1 g powder for solution for injection/infusion
Active SubstancesCeftriaxone sodium
Dosage FormPowder for solution for injection/infusion
Licence HolderAS Kalceks
Licence NumberPA2165/017/001

Group Information

ATC CodeJ01DD Third-generation cephalosporins
J01DD04 ceftriaxone


License statusAuthorised
Licence Issued13/01/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back